169 related articles for article (PubMed ID: 12691534)
21. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
Mellbye BL; Puckett SE; Tilley LD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2009 Feb; 53(2):525-30. PubMed ID: 19015356
[TBL] [Abstract][Full Text] [Related]
22. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
Geller BL; Deere J; Tilley L; Iversen PL
J Antimicrob Chemother; 2005 Jun; 55(6):983-8. PubMed ID: 15872045
[TBL] [Abstract][Full Text] [Related]
23. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
Sekhon HS; London CA; Sekhon M; Iversen PL; Devi GR
Lung Cancer; 2008 Jun; 60(3):347-54. PubMed ID: 18096271
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.
Alonso M; Stein DA; Thomann E; Moulton HM; Leong JC; Iversen P; Mourich DV
J Fish Dis; 2005 Jul; 28(7):399-410. PubMed ID: 16083445
[TBL] [Abstract][Full Text] [Related]
25. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
Moulton HM; Fletcher S; Neuman BW; McClorey G; Stein DA; Abes S; Wilton SD; Buchmeier MJ; Lebleu B; Iversen PL
Biochem Soc Trans; 2007 Aug; 35(Pt 4):826-8. PubMed ID: 17635157
[TBL] [Abstract][Full Text] [Related]
26. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture.
Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ
Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463
[TBL] [Abstract][Full Text] [Related]
27. Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth.
Neuman BW; Stein DA; Kroeker AD; Paulino AD; Moulton HM; Iversen PL; Buchmeier MJ
J Virol; 2004 Jun; 78(11):5891-9. PubMed ID: 15140987
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.
Amantana A; Moulton HM; Cate ML; Reddy MT; Whitehead T; Hassinger JN; Youngblood DS; Iversen PL
Bioconjug Chem; 2007; 18(4):1325-31. PubMed ID: 17583927
[TBL] [Abstract][Full Text] [Related]
29. Gene silencing using a conjugate comprising Tat peptide and antisense oligonucleotide with phosphorothioate backbones.
Maegawa Y; Mochizuki S; Miyamoto N; Sakurai K
Bioorg Med Chem Lett; 2016 Feb; 26(4):1276-8. PubMed ID: 26774656
[TBL] [Abstract][Full Text] [Related]
30. Phosphorodiamidate morpholino antisense oligomers inhibit expression of human cytochrome P450 3A4 and alter selected drug metabolism.
Arora V; Cate ML; Ghosh C; Iversen PL
Drug Metab Dispos; 2002 Jul; 30(7):757-62. PubMed ID: 12065433
[TBL] [Abstract][Full Text] [Related]
31. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
[TBL] [Abstract][Full Text] [Related]
32. Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.
Nan Y; Zhang YJ
Front Microbiol; 2018; 9():750. PubMed ID: 29731743
[TBL] [Abstract][Full Text] [Related]
33. Efficient systemic CNS delivery of a therapeutic antisense oligonucleotide with a blood-brain barrier-penetrating ApoE-derived peptide.
Yeoh YQ; Amin A; Cuic B; Tomas D; Turner BJ; Shabanpoor F
Biomed Pharmacother; 2024 Jun; 175():116737. PubMed ID: 38749176
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
35. Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models.
Burrer R; Neuman BW; Ting JP; Stein DA; Moulton HM; Iversen PL; Kuhn P; Buchmeier MJ
J Virol; 2007 Jun; 81(11):5637-48. PubMed ID: 17344287
[TBL] [Abstract][Full Text] [Related]
36. In Vitro Validation of Phosphorodiamidate Morpholino Oligomers.
Aung-Htut MT; McIntosh CS; West KA; Fletcher S; Wilton SD
Molecules; 2019 Aug; 24(16):. PubMed ID: 31408997
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
Endo-Munoz L; Warby T; Harrich D; McMillan NA
Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
[TBL] [Abstract][Full Text] [Related]
38. In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors.
Devi GR; Beer TM; Corless CL; Arora V; Weller DL; Iversen PL
Clin Cancer Res; 2005 May; 11(10):3930-8. PubMed ID: 15897595
[TBL] [Abstract][Full Text] [Related]
39. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
Brès V; Gomes N; Pickle L; Jones KA
Genes Dev; 2005 May; 19(10):1211-26. PubMed ID: 15905409
[TBL] [Abstract][Full Text] [Related]
40. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
Enterlein S; Warfield KL; Swenson DL; Stein DA; Smith JL; Gamble CS; Kroeker AD; Iversen PL; Bavari S; Mühlberger E
Antimicrob Agents Chemother; 2006 Mar; 50(3):984-93. PubMed ID: 16495261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
